DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
SOTAGLIFLOZIN
2023
Small molecule
Approved
Unknown
Unknown
Kidney Diseases; Liver Diseases; Heart Failure; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus
Sodium/glucose cotransporter 1 inhibitor
SOTAGLIFLOZIN
×
Maximum Phase:
4
First Approval:
2023
UNII:
6B4ZBS263Y
Molecule Type:
Small molecule
Molecular Formula:
C21H25ClO5S
Molecular Weight:
424.95
AlogP:
3.17
PSA:
79.15
HBD:
3.0
HBA:
#RotB:
6.0
Source:
PIRTOBRUTINIB
2023
Small molecule
Approved
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Mantle-Cell
Tyrosine-protein kinase BTK inhibitor
PIRTOBRUTINIB
×
Maximum Phase:
4
First Approval:
2023
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C22H21F4N5O3
Molecular Weight:
479.43
AlogP:
3.43
PSA:
125.26
HBD:
3.0
HBA:
#RotB:
7.0
Source:
DAPRODUSTAT
2023
Small molecule
Approved
Unknown
Unknown
Wounds and Injuries; Peripheral Vascular Diseases; Anemia
Hypoxia-inducible factor prolyl hydroxylase inhibitor
DAPRODUSTAT
×
Maximum Phase:
4
First Approval:
2023
UNII:
JVR38ZM64B
Molecule Type:
Small molecule
Molecular Formula:
C19H27N3O6
Molecular Weight:
393.44
AlogP:
1.26
PSA:
124.09
HBD:
2.0
HBA:
#RotB:
5.0
Source:
PALOVAROTENE
2023
Small molecule
Approved
Unknown
Unknown
Dry Eye Syndromes; Myositis Ossificans
Retinoic acid receptor gamma agonist
PALOVAROTENE
×
Maximum Phase:
4
First Approval:
2023
UNII:
28K6I5M16G
Molecule Type:
Small molecule
Molecular Formula:
C27H30N2O2
Molecular Weight:
414.55
AlogP:
6.15
PSA:
55.12
HBD:
1.0
HBA:
#RotB:
5.0
Source:
FRUQUINTINIB
2023
Small molecule
Approved
Unknown
Unknown
Breast Neoplasms; Stomach Neoplasms; Lung Neoplasms; Neoplasms; Rectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms
Vascular endothelial growth factor receptor inhibitor
FRUQUINTINIB
×
Maximum Phase:
4
First Approval:
2023
UNII:
49DXG3M5ZW
Molecule Type:
Small molecule
Molecular Formula:
C21H19N3O5
Molecular Weight:
393.4
AlogP:
3.85
PSA:
95.71
HBD:
1.0
HBA:
#RotB:
5.0
Source:
ETRASIMOD
2023
Small molecule
Approved
Unknown
Unknown
Alopecia Areata; Crohn Disease; Dermatitis, Atopic; Eosinophilic Esophagitis; Inflammatory Bowel Diseases; Liver Cirrhosis, Biliary; Pyoderma; Colitis, Ulcerative
Sphingosine 1-phosphate receptor Edg-1 agonist
ETRASIMOD
×
Maximum Phase:
4
First Approval:
2023
UNII:
6WH8495MMH
Molecule Type:
Small molecule
Molecular Formula:
C26H26F3NO3
Molecular Weight:
457.49
AlogP:
6.93
PSA:
62.32
HBD:
2.0
HBA:
#RotB:
6.0
Source:
OMAVELOXOLONE
2023
Small molecule
Approved
Unknown
Unknown
Liver Diseases; Melanoma; Breast Neoplasms; Friedreich Ataxia
Unknown
OMAVELOXOLONE
×
Maximum Phase:
4
First Approval:
2023
UNII:
G69Z98951Q
Molecule Type:
Small molecule
Molecular Formula:
C33H44F2N2O3
Molecular Weight:
554.72
AlogP:
6.73
PSA:
87.03
HBD:
1.0
HBA:
#RotB:
2.0
Source:
LOTILANER
2023
Small molecule
Approved
Unknown
Unknown
Blepharitis
Unknown
LOTILANER
×
Maximum Phase:
4
First Approval:
2023
UNII:
HEH4938D7K
Molecule Type:
Small molecule
Molecular Formula:
C20H14Cl3F6N3O3S
Molecular Weight:
596.76
AlogP:
6.01
PSA:
79.79
HBD:
2.0
HBA:
#RotB:
6.0
Source:
NIROGACESTAT
2023
Small molecule
Approved
Unknown
Unknown
Multiple Myeloma; Neoplasms; Breast Neoplasms; Pancreatic Neoplasms; Fibromatosis, Aggressive
Unknown
NIROGACESTAT
×
Maximum Phase:
4
First Approval:
2023
UNII:
QZ62892OFJ
Molecule Type:
Small molecule
Molecular Formula:
C27H41F2N5O
Molecular Weight:
489.66
AlogP:
4.79
PSA:
70.98
HBD:
3.0
HBA:
#RotB:
10.0
Source:
SPARSENTAN
2023
Small molecule
Approved
Unknown
Unknown
Hypertension; Glomerulonephritis, IGA; Glomerulosclerosis, Focal Segmental
Endothelin receptor ET-A antagonist
SPARSENTAN
×
Maximum Phase:
4
First Approval:
2023
UNII:
9242RO5URM
Molecule Type:
Small molecule
Molecular Formula:
C32H40N4O5S
Molecular Weight:
592.76
AlogP:
6.54
PSA:
114.1
HBD:
1.0
HBA:
#RotB:
12.0
Source:
LENIOLISIB
2023
Small molecule
Approved
Unknown
Unknown
Unknown
PI3-kinase p110-delta subunit inhibitor
LENIOLISIB
×
Maximum Phase:
4
First Approval:
2023
UNII:
L22772Z9CP
Molecule Type:
Small molecule
Molecular Formula:
C21H25F3N6O2
Molecular Weight:
450.47
AlogP:
2.88
PSA:
83.48
HBD:
1.0
HBA:
#RotB:
5.0
Source:
IPTACOPAN
2023
Small molecule
Approved
Unknown
Unknown
Glomerulonephritis; Glomerulonephritis, Membranous; Atypical Hemolytic Uremic Syndrome; Glomerulonephritis, IGA; Hemoglobinuria, Paroxysmal
Complement factor B inhibitor
IPTACOPAN
×
Maximum Phase:
4
First Approval:
2023
UNII:
8E05T07Z6W
Molecule Type:
Small molecule
Molecular Formula:
C25H30N2O4
Molecular Weight:
422.53
AlogP:
4.93
PSA:
74.79
HBD:
2.0
HBA:
#RotB:
7.0
Source:
VAMOROLONE
2023
Small molecule
Approved
Unknown
Unknown
Colitis, Ulcerative; Muscular Dystrophy, Duchenne
Unknown
VAMOROLONE
×
Maximum Phase:
4
First Approval:
2023
UNII:
8XP29XMB43
Molecule Type:
Small molecule
Molecular Formula:
C23H30O3
Molecular Weight:
354.49
AlogP:
4.17
PSA:
54.37
HBD:
1.0
HBA:
#RotB:
2.0
Source:
REZAFUNGIN
2023
Small molecule
Approved
Unknown
Unknown
Mycoses
Unknown
REZAFUNGIN
×
Maximum Phase:
4
First Approval:
2023
UNII:
G013B5478J
Molecule Type:
Small molecule
Molecular Formula:
C63H85N8O17+
Molecular Weight:
1226.41
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
BEXAGLIFLOZIN
2023
Small molecule
Approved
Unknown
Unknown
Essential Hypertension; Diabetes Mellitus; Diabetes Mellitus, Type 2
Sodium/glucose cotransporter 2 inhibitor
BEXAGLIFLOZIN
×
Maximum Phase:
4
First Approval:
2023
UNII:
EY00JF42FV
Molecule Type:
Small molecule
Molecular Formula:
C24H29ClO7
Molecular Weight:
464.94
AlogP:
2.0
PSA:
108.61
HBD:
4.0
HBA:
#RotB:
9.0
Source:
CAPIVASERTIB
2023
Small molecule
Approved
Unknown
Unknown
Endometrial Neoplasms; Fallopian Tube Neoplasms; Hematologic Neoplasms; Hereditary Breast and Ovarian Cancer Syndrome; Ovarian Neoplasms; Uterine Cervical Neoplasms; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Multiple Myeloma; Neoplasms; Prostatic Neoplasms; Stomach Neoplasms; Breast Neoplasms; Prostatic Neoplasms, Castration-Resistant
Serine/threonine-protein kinase AKT inhibitor
CAPIVASERTIB
×
Maximum Phase:
4
First Approval:
2023
UNII:
WFR23M21IE
Molecule Type:
Small molecule
Molecular Formula:
C21H25ClN6O2
Molecular Weight:
428.92
AlogP:
2.15
PSA:
120.16
HBD:
4.0
HBA:
#RotB:
6.0
Source:
ZAVEGEPANT
2023
Small molecule
Unknown
Unknown
Unknown
Severe Acute Respiratory Syndrome; Migraine Disorders
Unknown
ZAVEGEPANT
×
Maximum Phase:
4
First Approval:
2023
UNII:
ODU3ZAZ94J
Molecule Type:
Small molecule
Molecular Formula:
C36H46N8O3
Molecular Weight:
638.82
AlogP:
3.45
PSA:
120.67
HBD:
3.0
HBA:
#RotB:
6.0
Source:
FEZOLINETANT
2023
Small molecule
Approved
Unknown
Unknown
Kidney Diseases; Liver Diseases; Hot Flashes
Neurokinin 3 receptor antagonist
FEZOLINETANT
×
Maximum Phase:
4
First Approval:
2023
UNII:
83VNE45KXX
Molecule Type:
Small molecule
Molecular Formula:
C16H15FN6OS
Molecular Weight:
358.4
AlogP:
2.46
PSA:
76.8
HBD:
0.0
HBA:
#RotB:
2.0
Source:
ZURANOLONE
2023
Small molecule
Approved
Unknown
Unknown
Depressive Disorder; Essential Tremor; Parkinson Disease; Depression, Postpartum; Depressive Disorder, Major
Unknown
ZURANOLONE
×
Maximum Phase:
4
First Approval:
2023
UNII:
7ZW49N180B
Molecule Type:
Small molecule
Molecular Formula:
C25H35N3O2
Molecular Weight:
409.57
AlogP:
4.34
PSA:
78.91
HBD:
1.0
HBA:
#RotB:
3.0
Source:
RESMETIROM
2024
Small molecule
Approved
Unknown
Unknown
Hyperlipoproteinemia Type II; Non-alcoholic Fatty Liver Disease
Thyroid hormone receptor beta-1 agonist
RESMETIROM
×
Maximum Phase:
4
First Approval:
2024
UNII:
RE0V0T1ES0
Molecule Type:
Small molecule
Molecular Formula:
C17H12Cl2N6O4
Molecular Weight:
435.23
AlogP:
2.1
PSA:
146.52
HBD:
2.0
HBA:
#RotB:
4.0
Source:
VADADUSTAT
2024
Small molecule
Approved
Unknown
Unknown
Liver Diseases; Renal Insufficiency, Chronic; Anemia
Egl nine homolog 1 inhibitor
VADADUSTAT
×
Maximum Phase:
4
First Approval:
2024
UNII:
I60W9520VV
Molecule Type:
Small molecule
Molecular Formula:
C14H11ClN2O4
Molecular Weight:
306.71
AlogP:
1.92
PSA:
99.52
HBD:
3.0
HBA:
#RotB:
4.0
Source:
ARIMOCLOMOL
2024
Small molecule
Approved
Unknown
Unknown
Gaucher Disease; Niemann-Pick Disease, Type C; Amyotrophic Lateral Sclerosis; Myositis, Inclusion Body
Unknown
ARIMOCLOMOL
×
Maximum Phase:
4
First Approval:
2024
UNII:
EUT3557RT5
Molecule Type:
Small molecule
Molecular Formula:
C14H20ClN3O3
Molecular Weight:
313.79
AlogP:
1.08
PSA:
72.0
HBD:
1.0
HBA:
#RotB:
6.0
Source:
VORASIDENIB
2024
Small molecule
Approved
Unknown
Unknown
Glioma
IDH1/IDH2 inhibitor
VORASIDENIB
×
Maximum Phase:
4
First Approval:
2024
UNII:
789Q85GA8P
Molecule Type:
Small molecule
Molecular Formula:
C14H13ClF6N6
Molecular Weight:
414.74
AlogP:
4.31
PSA:
75.62
HBD:
2.0
HBA:
#RotB:
5.0
Source:
IOMEPROL
2024
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
IOMEPROL
×
Maximum Phase:
4
First Approval:
2024
UNII:
17E17JBP8L
Molecule Type:
Small molecule
Molecular Formula:
C17H22I3N3O8
Molecular Weight:
777.09
AlogP:
-1.38
PSA:
179.66
HBD:
7.0
HBA:
#RotB:
10.0
Source:
INAVOLISIB
2024
Small molecule
Approved
Unknown
Unknown
Breast Neoplasms; Neoplasms
PI3-kinase p110-alpha subunit inhibitor
INAVOLISIB
×
Maximum Phase:
4
First Approval:
2024
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C18H19F2N5O4
Molecular Weight:
407.38
AlogP:
1.82
PSA:
111.71
HBD:
2.0
HBA:
#RotB:
5.0
Source:
ELAFIBRANOR
2024
Small molecule
Approved
Unknown
Unknown
Liver Diseases; Diabetes Mellitus, Type 2; Non-alcoholic Fatty Liver Disease; Liver Cirrhosis, Biliary
Peroxisome proliferator-activated receptor alpha agonist
ELAFIBRANOR
×
Maximum Phase:
4
First Approval:
2024
UNII:
2J3H5C81A5
Molecule Type:
Small molecule
Molecular Formula:
C22H24O4S
Molecular Weight:
384.5
AlogP:
5.16
PSA:
63.6
HBD:
1.0
HBA:
#RotB:
7.0
Source:
SELADELPAR
2024
Small molecule
Approved
Unknown
Unknown
Liver Diseases; Cholangitis, Sclerosing; Hyperlipidemias; Hyperlipoproteinemia Type II; Non-alcoholic Fatty Liver Disease; Liver Cirrhosis, Biliary
Peroxisome proliferator-activated receptor delta agonist
SELADELPAR
×
Maximum Phase:
4
First Approval:
2024
UNII:
7C00L34NB9
Molecule Type:
Small molecule
Molecular Formula:
C21H23F3O5S
Molecular Weight:
444.47
AlogP:
5.05
PSA:
64.99
HBD:
1.0
HBA:
#RotB:
11.0
Source:
MAVORIXAFOR
2024
Small molecule
Approved
Unknown
Unknown
Carcinoma, Renal Cell; HIV Infections; Melanoma; Neutropenia; Waldenstrom Macroglobulinemia
C-X-C chemokine receptor type 4 antagonist
MAVORIXAFOR
×
Maximum Phase:
4
First Approval:
2024
UNII:
0G9LGB5O2W
Molecule Type:
Small molecule
Molecular Formula:
C21H27N5
Molecular Weight:
349.48
AlogP:
3.58
PSA:
70.83
HBD:
2.0
HBA:
#RotB:
7.0
Source:
SOFPIRONIUM
2024
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
SOFPIRONIUM
×
Maximum Phase:
4
First Approval:
2024
UNII:
00Y6A5AJU6
Molecule Type:
Small molecule
Molecular Formula:
C22H32NO5+
Molecular Weight:
390.5
AlogP:
2.39
PSA:
72.83
HBD:
1.0
HBA:
#RotB:
7.0
Source:
LANDIOLOL
2024
Small molecule
Approved
Unknown
Unknown
Arrhythmias, Cardiac; Atrial Fibrillation; Cardiovascular Diseases; Shock, Septic
Beta-1 adrenergic receptor antagonist
LANDIOLOL
×
Maximum Phase:
4
First Approval:
2024
UNII:
62NWQ924LH
Molecule Type:
Small molecule
Molecular Formula:
C25H39N3O8
Molecular Weight:
509.6
AlogP:
0.69
PSA:
127.82
HBD:
3.0
HBA:
#RotB:
13.0
Source:
APROCITENTAN
2024
Small molecule
Approved
Unknown
Unknown
Kidney Diseases; Liver Diseases; Essential Hypertension; Hypertension
Endothelin receptor, ET-A/ET-B antagonist
APROCITENTAN
×
Maximum Phase:
4
First Approval:
2024
UNII:
MZI81HV01P
Molecule Type:
Small molecule
Molecular Formula:
C16H14Br2N6O4S
Molecular Weight:
546.2
AlogP:
2.53
PSA:
142.21
HBD:
2.0
HBA:
#RotB:
8.0
Source:
ENSIFENTRINE
2024
Small molecule
Approved
Unknown
Unknown
Asthma; Cystic Fibrosis; Severe Acute Respiratory Syndrome; Pulmonary Disease, Chronic Obstructive
Unknown
ENSIFENTRINE
×
Maximum Phase:
4
First Approval:
2024
UNII:
3E3D8T1GIX
Molecule Type:
Small molecule
Molecular Formula:
C26H31N5O4
Molecular Weight:
477.57
AlogP:
2.72
PSA:
112.87
HBD:
2.0
HBA:
#RotB:
6.0
Source:
GIVINOSTAT
2024
Small molecule
Approved
Unknown
Unknown
Crohn Disease; Hodgkin Disease; Polycythemia Vera; Arthritis, Juvenile; Leukemia, Lymphocytic, Chronic, B-Cell; Multiple Myeloma; Myeloproliferative Disorders; Muscular Dystrophy, Duchenne
Unknown
GIVINOSTAT
×
Maximum Phase:
4
First Approval:
2024
UNII:
5P60F84FBH
Molecule Type:
Small molecule
Molecular Formula:
C24H27N3O4
Molecular Weight:
421.5
AlogP:
4.55
PSA:
90.9
HBD:
3.0
HBA:
#RotB:
8.0
Source:
ACORAMIDIS
2024
Small molecule
Approved
Unknown
Unknown
Amyloidosis; Amyloid Neuropathies, Familial
Transthyretin stabiliser
ACORAMIDIS
×
Maximum Phase:
4
First Approval:
2024
UNII:
T12B44A1OE
Molecule Type:
Small molecule
Molecular Formula:
C15H17FN2O3
Molecular Weight:
292.31
AlogP:
2.88
PSA:
75.21
HBD:
2.0
HBA:
#RotB:
6.0
Source:
LAZERTINIB
2024
Small molecule
Approved
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
Unknown
LAZERTINIB
×
Maximum Phase:
4
First Approval:
2024
UNII:
4A2Y23XK11
Molecule Type:
Small molecule
Molecular Formula:
C30H34N8O3
Molecular Weight:
554.66
AlogP:
4.1
PSA:
109.67
HBD:
2.0
HBA:
#RotB:
10.0
Source:
1
2
…
56
57
58
59
60
61
62
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA